HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spiked Supplement Holiday Deliveries Stopped By Import Examinations

This article was originally published in The Rose Sheet

Executive Summary

FDA alerts consumers and health care providers to 13 products found in examinations of international mail shipments to contain sildenafil and one with the banned drug sibutramine.

You may also be interested in...



Both Sildenafil And Tadalafil Found In Spiked Supplements

FDA finds products promoted for sexual enhancement and with brands such as "Man of Steel" and "Royal Master" contain one or both of tadalafil or sildenafil, active ingredients in prescription drugs indicated for ED.

Hemorrhoid, Lice Treatments Join Usual Suspects On FDA Import Alerts

"Detention without physical examination" alerts were ordered for the products because evidence exists that they are marketed or promoted as unapproved drugs to consumers in the US.

Herbal Sleep Aid With Rx 'Reformulation' Gives FDA A Nightmare

FDA inspects Belmora's website and product labeling in March and issues a warning letter that firm’s Elavil OTC Sleep Aid is an unapproved new drug with inadequate directions for its intended use.

Related Content

Topics

UsernamePublicRestriction

Register

RS108982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel